TP53 and acute lymphoblastic leukemia: This would require sequencing studies in large numbers of childhood ALL cases across different Hispanic/Latino populations in the Americas, which may also discover population-specific founder mutations that predispose to ALL similar to the Brazilian founder mutation in TP53 (97).